Caffeine Dose Response Study To Support Category I Status Proposed By BMS
This article was originally published in The Tan Sheet
Executive Summary
A placebo-controlled, dose-response trial comparing acetaminophen to combinations of caffeine with aspirin and acetaminophen has been proposed by Bristol-Myers Squibb.